| Q24337843 | A BEN-domain-containing protein associates with heterochromatin and represses transcription |
| Q39438764 | A genomic survey of HECT ubiquitin ligases in eukaryotes reveals independent expansions of the HECT system in several lineages |
| Q49685325 | A novel loss-of-function mutation in HACE1 is linked to a genetic disorder in a patient from India. |
| Q57216715 | Aspects moléculaires des lymphomes T périphériques (2) |
| Q47290680 | Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population |
| Q87754594 | Bayesian Cox Proportional Hazards Model in Survival Analysis of HACE1 Gene with Age at Onset of Alzheimer's Disease |
| Q54219436 | CNF1-like deamidase domains: common Lego bricks among cancer-promoting immunomodulatory bacterial virulence factors. |
| Q36881086 | Cell cycle regulation of Golgi membrane dynamics. |
| Q60046199 | Combined Genetic and Chromosomal Characterization of Wilms Tumors Identifies Chromosome 12 Gain as a Potential New Marker Predicting a Favorable Outcome |
| Q28943271 | Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma |
| Q37641476 | Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population. |
| Q35163343 | Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour |
| Q64067563 | Downregulation of CHIP promotes ovarian cancer metastasis by inducing Snail-mediated epithelial-mesenchymal transition |
| Q38606750 | E3 ubiquitin ligases in regulating stress fiber, lamellipodium, and focal adhesion dynamics |
| Q33356416 | Endocytic regulation of alkali metal transport proteins in mammals, yeast and plants |
| Q36250137 | Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype |
| Q39061540 | Epigenetic regulation of ANKRD18B in lung cancer |
| Q34898306 | Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets |
| Q30945124 | Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor |
| Q33677463 | Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type |
| Q57166441 | Genetic Predisposition to Neuroblastoma |
| Q57821557 | Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of in Wilms tumour susceptibility |
| Q39273903 | Genetic susceptibility to neuroblastoma |
| Q52339753 | Genetic susceptibility to neuroblastoma: current knowledge and future directions. |
| Q48152334 | Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan |
| Q49538387 | Group-I PAKs-mediated phosphorylation of HACE1 at serine 385 regulates its oligomerization state and Rac1 ubiquitination |
| Q36947062 | HACE1 Negatively Regulates Virus-Triggered Type I IFN Signaling by Impeding the Formation of the MAVS-TRAF3 Complex |
| Q27317217 | HACE1 deficiency causes an autosomal recessive neurodevelopmental syndrome |
| Q92008102 | HACE1 deficiency leads to structural and functional neurodevelopmental defects |
| Q60915973 | HACE1 is a potential tumor suppressor in osteosarcoma |
| Q36495194 | HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms |
| Q45305356 | HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo. |
| Q37612752 | HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response. |
| Q92008092 | HACE1, RAC1, and what else in the pathogenesis of SPPRS? |
| Q91760713 | HACE1, an E3 Ubiquitin Protein Ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus Infection-Induced Oxidative Stress by Promoting Nrf2 Activity |
| Q38351949 | HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress |
| Q37330142 | HACE1: A novel repressor of RAR transcriptional activity. |
| Q39124376 | Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes |
| Q38104533 | Hijacking of Rho GTPases during bacterial infection |
| Q42315389 | Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation. |
| Q37377572 | Lin28 promotes transformation and is associated with advanced human malignancies |
| Q36250061 | Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression |
| Q35287869 | Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction |
| Q36190308 | Metabolic context regulates distinct hypothalamic transcriptional responses to antiaging interventions |
| Q35027111 | Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood |
| Q64085662 | Molecular pathogenic pathways in extranodal NK/T cell lymphoma |
| Q33765905 | NKX6.3 Regulates Reactive Oxygen Species Production by Suppressing NF-kB and DNMT1 Activities in Gastric Epithelial Cells |
| Q54977052 | Optineurin: A Coordinator of Membrane-Associated Cargo Trafficking and Autophagy. |
| Q47797328 | Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. |
| Q91117876 | Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells |
| Q38289038 | Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications |
| Q29617293 | Physiological functions of the HECT family of ubiquitin ligases |
| Q90737693 | Physiopathological Bases of the Disease Caused by HACE1 Mutations: Alterations in Autophagy, Mitophagy and Oxidative Stress Response |
| Q90363458 | Rac1 Signaling: From Intestinal Homeostasis to Colorectal Cancer Metastasis |
| Q38933808 | Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors |
| Q38252591 | Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities |
| Q42333576 | TNF-driven cell fate: till HACE do us part |
| Q27318369 | The E3 ubiquitin ligase Hace1 is required for early embryonic development in Xenopus laevis |
| Q24294840 | The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1 |
| Q60019698 | The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation |
| Q42995400 | The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop |
| Q36968948 | The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate |
| Q43079289 | The expanding universe of hypoxia |
| Q38764772 | The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis. |
| Q90407308 | The pro-tumoral function of HACE1 |
| Q44525255 | The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation |
| Q24293051 | The ubiquitin ligase HACE1 regulates Golgi membrane dynamics during the cell cycle |
| Q93082132 | Ubiquitination and Long Non-coding RNAs Regulate Actin Cytoskeleton Regulators in Cancer Progression |
| Q38025873 | Ubiquitylation of active Rac1 by the E3 ubiquitin-ligase HACE1. |
| Q24300797 | Ubiquitylation of autophagy receptor Optineurin by HACE1 activates selective autophagy for tumor suppression |
| Q52668508 | Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells. |
| Q46287916 | hace1 Influences zebrafish cardiac development via ROS-dependent mechanisms |